Yüklüyor......
Gene therapy and genome editing for primary immunodeficiency diseases
In past two decades the gene therapy using genetic modified autologous hematopoietic stem cells (HSCs) transduced with the viral vector has become a promising alternative option for treating primary immunodeficiency diseases (PIDs). Despite of some pitfalls at early stage clinical trials, the field...
Kaydedildi:
| Yayımlandı: | Genes Dis |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Chongqing Medical University
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7063425/ https://ncbi.nlm.nih.gov/pubmed/32181274 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.gendis.2019.07.007 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|